Home/ Stocks/ KMDA

Kamada Ltd

KMDA XNAS

$7.27 +0.13 (+1.82%) ▲ 15-min delayed

Open

$7.17

High

$7.27

Low

$7.16

Volume

17.7K

Market Cap

$411.94M

About Kamada Ltd

Kamada Ltd is a drug-focused, plasma-derived protein therapeutics company. It is involved in the business of developing, producing, and marketing specialty therapeutics using protein purification proprietary technology. Its product portfolio consists of Glassia, Bramitob, Foster, Ixiaro, Factor-IX, and others. The company has two segments namely, the Proprietary Products segment and the Distribution segment. It derives the majority of its revenue from the Proprietary products segment. The firm categorizes its products in Lung Disease, Vaccines, Haemophilia, Immunoglobulins, Critical care, and Diagnostics.

Employees: 462 Website →

Related Market News

No specific coverage for KMDA yet. Check out our latest market news or earnings calendar.

Get KMDA Alerts

Stay ahead with breaking news, price alerts, and expert analysis on Kamada Ltd.

Disclaimer: This page is for informational purposes only. Stock data is delayed by at least 15 minutes. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.